7 Hills Pharma

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
7 Hills Pharma is an immunotherapy company developing novel small molecules to improve the effectiveness of immune checkpoint inhibitors for cancer and vaccines for infectious diseases. Our lead compound, 7HP349, is a first-in-concept integrin activator that stabilizes cell-cell interactions required for antigen presentation. 7HP349 improves the effectiveness of immune checkpoint inhibitors for cancer, as well as vaccines for influenza, and COVID-19. 7HP349 is the only systemically safe adjuvant that can activate both cellular and humoral immunity.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
Texas
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
7HP349, small molecule, first-in-concept integrin activator
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President & CEO
7 Hills Pharma